CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 33 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $50,000 | -86.4% | 17,400 | -66.6% | 0.01% | -88.5% |
| Q1 2015 | $369,000 | -47.4% | 52,100 | -48.1% | 0.05% | -55.9% |
| Q4 2014 | $701,000 | +946.3% | 100,300 | +855.2% | 0.12% | +883.3% |
| Q4 2013 | $67,000 | -43.2% | 10,500 | -13.9% | 0.01% | -55.6% |
| Q3 2013 | $118,000 | – | 12,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
| COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
| Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
| Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
| ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |